Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography.
In an azotemic patient with suspected renal artery stenosis, undiluted gadopentetate dimeglumine was administered in an aortic bolus to provide contrast at digital subtraction angiography of the aorta and renal arteries. The contrast material (5 mmol/mL) was power injected (rate, 15 mL/sec; total dose, 30 mL). Selective renal arteriography was also performed with 5 mL of undiluted gadopentetate dimeglumine hand injected into each renal artery (total dose, 40 mL). The patient tolerated the procedure without complication or worsening of renal function, and diagnostic angiographic images were obtained.
Department of Radiology, University of Arkansas for Medical Sciences, Little Rock 72205, USA.
W J
WJ
Matchett
D R
DR
McFarland
D K
DK
Russell
D M
DM
Sailors
M M
MM
Moursi
D000368:Aged; D000369:Aged, 80 and over; D015901:Angiography, Digital Subtraction; D017544:Aortic Aneurysm, Abdominal / Q000150:complications / Q000000981:diagnostic imaging; D003287:Contrast Media / Q000009:adverse effects; D004338:Drug Combinations; D019786:Gadolinium DTPA; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008297:Male; D008536:Meglumine / Q000009:adverse effects; D009942:Organometallic Compounds / Q000009:adverse effects; D004369:Pentetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D012078:Renal Artery Obstruction / Q000150:complications / Q000000981:diagnostic imaging; D014511:Uremia / Q000150:complications
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D019786:Gadolinium DTPA